Glaucoma Device Reduces IOP, Medication Need at 1 Year
A year after initial implantation, the shunt resulted in a 79% reduction in need for glaucoma medications, a study shows.
A year after initial implantation, the shunt resulted in a 79% reduction in need for glaucoma medications, a study shows.
Patients with an etiology of retinal vein occlusion have worse visual acuity 1 year after treatment with a drainage device than patients with proliferative diabetic retinopathy.